APLT INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit
Portfolio Pulse from
Robbins Geller Rudman & Dowd LLP has announced a class action lawsuit against Applied Therapeutics, Inc. (NASDAQ: APLT) for alleged violations of the Securities Exchange Act of 1934. Investors who purchased APLT securities between January 3, 2024, and December 2, 2024, have until February 18, 2025, to seek lead plaintiff status.
January 22, 2025 | 1:45 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
A class action lawsuit has been filed against Applied Therapeutics, Inc. for alleged violations of the Securities Exchange Act of 1934. This could negatively impact the stock price in the short term as legal issues often create uncertainty.
The announcement of a class action lawsuit typically creates uncertainty and can lead to a decline in stock price as investors react to potential legal and financial repercussions. The lawsuit alleges violations of the Securities Exchange Act, which is a serious charge that could affect investor confidence.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100